This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignees: Incospharm Corporation, Peotron Co. Ltd.. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: Seok-Jeong Yoon: Innovator in Cosmetic and Pharmaceutical Patents
Introduction
Seok-Jeong Yoon is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the fields of cosmetics and pharmaceuticals, holding three patents that showcase his innovative spirit and dedication to improving skin health.
Latest Patents
One of his latest patents is titled "Peptide analogues with an excellent moisturizing effect and use thereof." This invention relates to a peptide analog or a pharmaceutically acceptable salt that provides excellent moisturizing effects. It includes a method for preparation, a moisturizing cosmetic composition, and a pharmaceutical composition aimed at preventing and treating xeroderma. Another significant patent is the "Biotin-conjugated hexapeptide-2 derivative and use thereof." This invention focuses on a biotin-conjugated hexapeptide-2 derivative, detailing its preparation method and its application in improving wrinkles and inhibiting skin aging.
Career Highlights
Seok-Jeong Yoon has worked with reputable companies such as Incospharm Corporation and Peotron Co. Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, leading to the successful patenting of his inventions.
Collaborations
He has collaborated with notable coworkers, including Chae-Jin Lim and Seon-Deok Kwon, contributing to the advancement of their shared goals in the cosmetic and pharmaceutical industries.
Conclusion
Seok-Jeong Yoon's work exemplifies the intersection of innovation and practical application in the fields of cosmetics and pharmaceuticals. His patents reflect a commitment to enhancing skin health through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile